CLINDAMYCIN PALMITATE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
When do Clindamycin Palmitate Hydrochloride patents expire, and when can generic versions of Clindamycin Palmitate Hydrochloride launch?
Clindamycin Palmitate Hydrochloride is a drug marketed by Amneal Pharms, Appco, Aurobindo Pharma Ltd, Chartwell Rx, Extrovis, Padagis Us, and Rising. and is included in seven NDAs.
The generic ingredient in CLINDAMYCIN PALMITATE HYDROCHLORIDE is clindamycin palmitate hydrochloride. There is one drug master file entry for this compound. Nine suppliers are listed for this compound. Additional details are available on the clindamycin palmitate hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Clindamycin Palmitate Hydrochloride
A generic version of CLINDAMYCIN PALMITATE HYDROCHLORIDE was approved as clindamycin palmitate hydrochloride by RISING on August 28th, 2012.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for CLINDAMYCIN PALMITATE HYDROCHLORIDE?
- What are the global sales for CLINDAMYCIN PALMITATE HYDROCHLORIDE?
- What is Average Wholesale Price for CLINDAMYCIN PALMITATE HYDROCHLORIDE?
Summary for CLINDAMYCIN PALMITATE HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 7 |
| NDAs: | 7 |
| Finished Product Suppliers / Packagers: | 8 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Patent Applications: | 817 |
| DailyMed Link: | CLINDAMYCIN PALMITATE HYDROCHLORIDE at DailyMed |
Pharmacology for CLINDAMYCIN PALMITATE HYDROCHLORIDE
| Drug Class | Lincosamide Antibacterial |
| Physiological Effect | Decreased Sebaceous Gland Activity Neuromuscular Blockade |
Anatomical Therapeutic Chemical (ATC) Classes for CLINDAMYCIN PALMITATE HYDROCHLORIDE
US Patents and Regulatory Information for CLINDAMYCIN PALMITATE HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amneal Pharms | CLINDAMYCIN PALMITATE HYDROCHLORIDE | clindamycin palmitate hydrochloride | FOR SOLUTION;ORAL | 203513-001 | Mar 13, 2014 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Rising | CLINDAMYCIN PALMITATE HYDROCHLORIDE | clindamycin palmitate hydrochloride | FOR SOLUTION;ORAL | 201821-001 | Aug 28, 2012 | AA | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Chartwell Rx | CLINDAMYCIN PALMITATE HYDROCHLORIDE | clindamycin palmitate hydrochloride | FOR SOLUTION;ORAL | 206958-001 | May 5, 2017 | AA | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Appco | CLINDAMYCIN PALMITATE HYDROCHLORIDE | clindamycin palmitate hydrochloride | FOR SOLUTION;ORAL | 207047-001 | May 11, 2018 | AA | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Aurobindo Pharma Ltd | CLINDAMYCIN PALMITATE HYDROCHLORIDE | clindamycin palmitate hydrochloride | FOR SOLUTION;ORAL | 202409-001 | Apr 30, 2013 | AA | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Padagis Us | CLINDAMYCIN PALMITATE HYDROCHLORIDE | clindamycin palmitate hydrochloride | FOR SOLUTION;ORAL | 090902-001 | Jul 7, 2010 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Extrovis | CLINDAMYCIN PALMITATE HYDROCHLORIDE | clindamycin palmitate hydrochloride | FOR SOLUTION;ORAL | 203063-001 | May 25, 2016 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
